Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-02 4 OE $12.99 $38,970 I/I 3,000 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-03 4 AS $107.42 $537,097 D/D (5,000) 215,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-03 4 A $0.00 $0 D/D 39,600 254,757 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-04 4 OE $9.86 $4,930 I/I 500 43,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-04 4 AS $107.71 $98,660 I/I (916) 42,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-05 4 S $113.70 $1,137,016 I/I (10,000) 42,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-05 4 OE $12.99 $129,900 I/I 10,000 52,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-09 4 S $112.12 $2,130,383 I/I (19,000) 38,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-09 4 OE $12.99 $194,850 I/I 15,000 57,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-10 4 S $114.89 $232,201 I/I (2,021) 36,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-16 4 AS $123.48 $123,477 I/I (1,000) 35,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-17 4 AS $124.87 $124,866 I/I (1,000) 34,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-20 4 AS $126.40 $126,396 I/I (1,000) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $2,717,546 I/I (22,546) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $422,590 D/D (3,506) 251,251 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 OE $6.46 $145,647 I/I 22,546 55,804 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-30 4 A $51.26 $46,547 D/D 908 252,159 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $2,669,517 I/I (23,218) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $402,992 D/D (3,505) 248,654 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 OE $6.46 $149,988 I/I 23,218 56,476 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-08 4 D $121.66 $666,575 D/D (5,479) 243,175 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-12 4 D $121.09 $284,440 D/D (2,349) 240,826 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-15 4 D $122.78 $605,551 D/D (4,932) 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-21 4 S $126.10 $189,157 I/I (1,500) 31,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-06-04 4 D $120.46 $799,854 D/D (6,640) 229,254 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 15 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us